What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Biochemistry, Protein structure, Leucine-rich repeat, Nuclear transport and Nuclear localization sequence.
As part of his studies on Biochemistry, Bostjan Kobe often connects relevant areas like Biophysics.
His Protein structure study which covers NLR Proteins that intersects with Receptor complex and Arabidopsis.
His research in Leucine-rich repeat intersects with topics in Sequence motif, Nucleic acid, Ribonuclease inhibitor and Plasma protein binding.
His studies in Ribonuclease inhibitor integrate themes in fields like Pancreatic ribonuclease, Pentapeptide repeat and In vivo.
His Nuclear transport study combines topics from a wide range of disciplines, such as Nuclear protein, Computational biology and NLS.
His most cited work include:
- The leucine-rich repeat as a protein recognition motif (1299 citations)
- The leucine-rich repeat: a versatile binding motif. (1090 citations)
- Direct protein interaction underlies gene-for-gene specificity and coevolution of the flax resistance genes and flax rust avirulence genes (625 citations)
What are the main themes of his work throughout his whole career to date?
Bostjan Kobe spends much of his time researching Biochemistry, Cell biology, Protein structure, Computational biology and Crystallography.
His Biochemistry study frequently draws parallels with other fields, such as Biophysics.
His study focuses on the intersection of Protein structure and fields such as Leucine-rich repeat with connections in the field of Ribonuclease inhibitor.
His Crystallography research is multidisciplinary, incorporating elements of Crystallization and Protein–protein interaction.
His studies examine the connections between Kinase and genetics, as well as such issues in Phosphorylation, with regards to Peptide sequence.
Bostjan Kobe combines subjects such as Genetics and Function with his study of Effector.
He most often published in these fields:
- Biochemistry (38.29%)
- Cell biology (27.00%)
- Protein structure (20.66%)
What were the highlights of his more recent work (between 2018-2021)?
- Cell biology (27.00%)
- Crystal structure (9.09%)
- Innate immune system (6.89%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cell biology, Crystal structure, Innate immune system, Crystallography and Effector.
His studies deal with areas such as Mutagenesis, Receptor, In vitro and NAD+ kinase as well as Cell biology.
His Crystal structure research incorporates elements of Biophysics, Mutant, Drosophila and Stereochemistry.
His Crystallography study integrates concerns from other disciplines, such as Plant disease resistance, Mutagenesis, Tris, Glycerol and Ribose.
Bostjan Kobe has included themes like Immune receptor, Transgene, Secretion, Arabidopsis and Function in his Effector study.
Protein structure is a subfield of Biochemistry that Bostjan Kobe studies.
Between 2018 and 2021, his most popular works were:
- NAD+ cleavage activity by animal and plant TIR domains in cell death pathways (100 citations)
- The Plant "Resistosome": Structural Insights into Immune Signaling. (29 citations)
- Handling of nutrient copper in the bacterial envelope (23 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Cell biology, Effector, Innate immune system, Receptor and Inflammasome.
His work is dedicated to discovering how Cell biology, NAD+ kinase are connected with Allosteric regulation and Axon and other disciplines.
His Effector research integrates issues from Immune receptor, Transgene, Extracellular, Protein domain and Arabidopsis.
His Arabidopsis study is associated with Genetics.
His Innate immune system research is multidisciplinary, relying on both Signal transduction, Computational biology and Function.
His biological study spans a wide range of topics, including Antigen and Glycan.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
